$VMD insider trading
Over the last 12 months, Viemed Healthcare insiders reported no purchases and 26 sales totaling $2.5M across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $2.5M 26 events
- Events · 12m
- 26 Form 4 filings, grouped
- Insiders · 12m
- 10 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Heltz SabrinaD | ▽ Sale to issuer | 3,757 | $8.94 | $34K | -4.4% | — |
| Aug 19, 2026 | Dobbs Randy E.D | ▽ Sale to issuer | 4,191 | $8.94 | $37K | -2.9% | — |
| Aug 19, 2026 | Smokoff TimothyD | ▽ Sale to issuer | 3,757 | $8.94 | $34K | -4% | — |
| Jun 25, 2026 | Frazier WilliamChief Medical Officer · O·D | ▼ Sale | 10,000 | $11.72 | $117K | -12% | — |
| Jun 24, 2026 | Smokoff TimothyD | ▼ Sale | 20,000 | $11.5 | $230K | -20.9% | 5 tranches |
| Mar 20, 2026 | Moore MichaelPresident · O | ▼ Sale | 136,802 | $9.05 | $1.2M | -7.9% | 3 tranches · indirect |
| Jan 29, 2026 | Trahan JeremyGeneral Counsel · O | ▽ Sale to issuer | 3,591 | $7.48 | $27K | -7.2% | — |
| Jan 29, 2026 | Cambre JeromeVice President of Sales · O | ▽ Sale to issuer | 2,873 | $7.48 | $21K | -2.7% | — |
| Jan 29, 2026 | Frazier WilliamChief Medical Officer · O·D | ▽ Sale to issuer | 778 | $7.48 | $6K | -1.1% | — |
| Jan 29, 2026 | Fitzgerald TraeChief Financial Officer · O | ▽ Sale to issuer | 3,265 | $7.48 | $24K | -3% | — |
| Jan 29, 2026 | Moore MichaelPresident · O | ▽ Sale to issuer | 8,947 | $7.48 | $67K | -4.5% | — |
| Jan 29, 2026 | Hoyt CaseyChief Executive Officer · O·D | ▽ Sale to issuer | 13,265 | $7.48 | $99K | -3.6% | — |
| Jan 29, 2026 | ZEHNDER WILLIAM TODDChief Operating Officer · O·D | ▽ Sale to issuer | 8,948 | $7.48 | $67K | -2.2% | — |
| Jan 21, 2026 | Trahan JeremyGeneral Counsel · O | ▽ Sale to issuer | 3,662 | $7.49 | $27K | -8.7% | — |
| Jan 21, 2026 | Cambre JeromeVice President of Sales · O | ▽ Sale to issuer | 2,930 | $7.49 | $22K | -2.9% | — |
| Jan 21, 2026 | Frazier WilliamChief Medical Officer · O·D | ▽ Sale to issuer | 850 | $7.49 | $6K | -1.2% | — |
| Jan 21, 2026 | Fitzgerald TraeChief Financial Officer · O | ▽ Sale to issuer | 3,329 | $7.49 | $25K | -3.3% | — |
| Jan 21, 2026 | Moore MichaelPresident · O | ▽ Sale to issuer | 8,554 | $7.49 | $64K | -4.8% | — |
| Jan 21, 2026 | Hoyt CaseyChief Executive Officer · O·D | ▽ Sale to issuer | 12,400 | $7.49 | $93K | -3.7% | — |
| Jan 21, 2026 | ZEHNDER WILLIAM TODDChief Operating Officer · O·D | ▽ Sale to issuer | 8,554 | $7.49 | $64K | -2.2% | — |
| Jan 17, 2026 | Trahan JeremyGeneral Counsel · O | ▽ Sale to issuer | 1,221 | $7.33 | $9K | -4.1% | — |
| Jan 17, 2026 | Cambre JeromeVice President of Sales · O | ▽ Sale to issuer | 2,132 | $7.33 | $16K | -2.3% | — |
| Jan 17, 2026 | Fitzgerald TraeChief Financial Officer · O | ▽ Sale to issuer | 2,397 | $7.33 | $18K | -2.6% | — |
| Jan 17, 2026 | Moore MichaelPresident · O | ▽ Sale to issuer | 6,735 | $7.33 | $49K | -4.4% | — |
| Jan 17, 2026 | Hoyt CaseyChief Executive Officer · O·D | ▽ Sale to issuer | 10,017 | $7.33 | $73K | -3.4% | — |
| Jan 17, 2026 | ZEHNDER WILLIAM TODDChief Operating Officer · O·D | ▽ Sale to issuer | 6,735 | $7.33 | $49K | -2.3% | — |
| Aug 22, 2025 | Trahan JeremyGeneral Counsel · O | ▽ Sale to issuer | 2,986 | $7.31 | $22K | -12.4% | — |
| Aug 13, 2025 | Cambre JeromeVice President of Sales · O | ▼ Sale | 4,880 | $7.32 | $36K | -5.5% | 2 tranches |
| Aug 12, 2025 | Moore MichaelPresident · O | ▼ Sale | 50,090 | $7.33 | $367K | -28.4% | — |
Every $VMD filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Viemed Healthcare filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $VMD feed.